<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01387126</url>
  </required_header>
  <id_info>
    <org_study_id>004</org_study_id>
    <nct_id>NCT01387126</nct_id>
  </id_info>
  <brief_title>Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program</brief_title>
  <official_title>A Randomized, Controlled Trial Evaluating the Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program, on Body Weight in Overweight and Obese Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Center for Functional Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>InovoBiologic Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Center for Functional Medicine</source>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether the supplementation of a medically supervised
      weight management program with a novel fibre supplement, improves body weight, body
      composition, and laboratory measurements in overweight and obese individuals. All subjects
      will participate in the medical weight management program however the intervention group will
      have 5 grams of a novel fibre supplemented to each meal while the control group will not.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    No grant funding yet for this trial.
  </why_stopped>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Novel fibre supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The full dose of the study intervention is 15 grams per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weight management program</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Novel fibre supplement</intervention_name>
    <description>The full dose of the study intervention is 15 grams per day.</description>
    <arm_group_label>Novel fibre supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 27 - 30 Kg/m2 with 1 weight-related comorbidity and/or BMI 30 - 50 Kg/m2

          -  Ability to provide written informed consent in accordance with Good Clinical Practice
             (GCP) and local legislation in English

        Exclusion Criteria:

          -  Medications and supplements that affect body weight and appetite

          -  Type 2 diabetes on insulin treatment

          -  Contraindications to low calorie diet

          -  Any allergies to study product ingredients

          -  Any other medical, social or geographic condition, which, in the opinion of the
             investigator would not allow safe completion of the protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael R Lyon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Canadian Centre for Functional Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Canadian Centre for Functional Medicine</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <zip>V7L1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2011</study_first_submitted>
  <study_first_submitted_qc>July 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2011</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

